Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model
During the last two decades, the introduction of tyrosine kinase inhibitors (TKIs) to the therapy has changed the natural history of CML but progression into accelerated and blast phase (AP/BP) occurs in 3-5% of cases, especially in patients resistant to several lines of TKIs. In TKI-refractory pati...
| 出版年: | Frontiers in Immunology |
|---|---|
| 主要な著者: | Jusuf Imeri, Paul Marcoux, Matthias Huyghe, Christophe Desterke, Daianne Maciely Carvalho Fantacini, Frank Griscelli, Dimas T. Covas, Lucas Eduardo Botelho de Souza, Annelise Bennaceur Griscelli, Ali G. Turhan |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Frontiers Media S.A.
2024-01-01
|
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1309010/full |
類似資料
Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities
著者:: Matthias Huyghe, 等
出版事項: (2024-10-01)
著者:: Matthias Huyghe, 等
出版事項: (2024-10-01)
Regulation of Tetraspanin CD63 in Chronic Myeloid Leukemia (CML): Single-Cell Analysis of Asymmetric Hematopoietic Stem Cell Division Genes
著者:: Christophe Desterke, 等
出版事項: (2025-07-01)
著者:: Christophe Desterke, 等
出版事項: (2025-07-01)
Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance
著者:: Jusuf Imeri, 等
出版事項: (2023-03-01)
著者:: Jusuf Imeri, 等
出版事項: (2023-03-01)
HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease
著者:: Christophe Desterke, 等
出版事項: (2021-07-01)
著者:: Christophe Desterke, 等
出版事項: (2021-07-01)
Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy
著者:: Masae Kishi, 等
出版事項: (2021-12-01)
著者:: Masae Kishi, 等
出版事項: (2021-12-01)
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
著者:: Ali G. Turhan, 等
出版事項: (2021-10-01)
著者:: Ali G. Turhan, 等
出版事項: (2021-10-01)
Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
著者:: Paul Marcoux, 等
出版事項: (2023-12-01)
著者:: Paul Marcoux, 等
出版事項: (2023-12-01)
Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)
著者:: Jusuf Imeri, 等
出版事項: (2023-02-01)
著者:: Jusuf Imeri, 等
出版事項: (2023-02-01)
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia
著者:: Seda Baykal, 等
出版事項: (2023-06-01)
著者:: Seda Baykal, 等
出版事項: (2023-06-01)
Identification of spectral modifications occurring during reprogramming of somatic cells.
著者:: Christophe Sandt, 等
出版事項: (2012-01-01)
著者:: Christophe Sandt, 等
出版事項: (2012-01-01)
Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model
著者:: Ladan Kobari, 等
出版事項: (2012-12-01)
著者:: Ladan Kobari, 等
出版事項: (2012-12-01)
Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Harbor Short and Unstable Telomeres Leading to Chromosomal Instability
著者:: Radhia M’Kacher, 等
出版事項: (2022-01-01)
著者:: Radhia M’Kacher, 等
出版事項: (2022-01-01)
Prevention of bone marrow graft failure by an anti LFA-1 monoclonal antibody
著者:: A. Fischer, 等
出版事項: (1987-01-01)
著者:: A. Fischer, 等
出版事項: (1987-01-01)
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
著者:: Renata Nacasaki Silvestre, 等
出版事項: (2023-09-01)
著者:: Renata Nacasaki Silvestre, 等
出版事項: (2023-09-01)
Protective Vaccination Reshapes Hepatic Response to Blood-Stage Malaria of Genes Preferentially Expressed by NK Cells
著者:: Marcos J. Araúzo-Bravo, 等
出版事項: (2020-11-01)
著者:: Marcos J. Araúzo-Bravo, 等
出版事項: (2020-11-01)
Tailored CML Treatment in Indonesia, Let’s See More
著者:: Shinta Oktya Wardhani
出版事項: (2023-11-01)
著者:: Shinta Oktya Wardhani
出版事項: (2023-11-01)
Survival of Patients with CML on Imatinib Experience with 44 Iraqi Patients
著者:: Ali M. Jawad, 等
出版事項: (2008-10-01)
著者:: Ali M. Jawad, 等
出版事項: (2008-10-01)
A novel NKp80-based strategy for universal identification of normal, reactive and tumor/clonal natural killer-cells in blood
著者:: F. Javier Morán-Plata, 等
出版事項: (2024-07-01)
著者:: F. Javier Morán-Plata, 等
出版事項: (2024-07-01)
Dilemmas in the Diagnosis and Management of CML in Pakistan
著者:: Sahrish Khan, 等
出版事項: (2024-12-01)
著者:: Sahrish Khan, 等
出版事項: (2024-12-01)
In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells
著者:: Amanda G. Tomalka, 等
出版事項: (2018-11-01)
著者:: Amanda G. Tomalka, 等
出版事項: (2018-11-01)
Editorial: Women in NK and innate lymphoid cell biology
著者:: Alessandra Zingoni, 等
出版事項: (2023-02-01)
著者:: Alessandra Zingoni, 等
出版事項: (2023-02-01)
A Brief Analysis of Tissue-Resident NK Cells in Pregnancy and Endometrial Diseases: The Importance of Pharmacologic Modulation
著者:: Jenny Valentina Garmendia, 等
出版事項: (2021-07-01)
著者:: Jenny Valentina Garmendia, 等
出版事項: (2021-07-01)
Flow cytometry analysis of cytotoxic cells in patients with chronic hepatitis C
著者:: M. S. Selkova
出版事項: (2014-09-01)
著者:: M. S. Selkova
出版事項: (2014-09-01)
g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood
著者:: Fei Gao, 等
出版事項: (2023-12-01)
著者:: Fei Gao, 等
出版事項: (2023-12-01)
NK cell-based tumor immunotherapy
著者:: Hao Zhang, 等
出版事項: (2024-01-01)
著者:: Hao Zhang, 等
出版事項: (2024-01-01)
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
著者:: Yan Yang, 等
出版事項: (2020-09-01)
著者:: Yan Yang, 等
出版事項: (2020-09-01)
Feeder cell training shapes the phenotype and function of in vitro expanded natural killer cells
著者:: Fei Gao, 等
出版事項: (2024-10-01)
著者:: Fei Gao, 等
出版事項: (2024-10-01)
The problem of Arabization and the crisis of Westernization - Abdullah Kharet - a model
著者:: hadja bennaceur
出版事項: (2024-04-01)
著者:: hadja bennaceur
出版事項: (2024-04-01)
Analyse des données quantitatives : cas de l’enquête par questionnaire
著者:: Ilyas BENNACEUR
出版事項: (2022-10-01)
著者:: Ilyas BENNACEUR
出版事項: (2022-10-01)
LES LANGUES DANS LES ENSEIGNES COMMERCIALES DE LA VILLE DE BATNA
著者:: Ilyas Bennaceur
出版事項: (2021-12-01)
著者:: Ilyas Bennaceur
出版事項: (2021-12-01)
What Defines NK Cell Functional Fate: Phenotype or Metabolism?
著者:: Sophie M. Poznanski, 等
出版事項: (2019-06-01)
著者:: Sophie M. Poznanski, 等
出版事項: (2019-06-01)
The Impact of High-Fat Diet and Restrictive Feeding on Natural Killer Cells in Obese-Resistant BALB/c Mice
著者:: Julia Spielmann, 等
出版事項: (2021-07-01)
著者:: Julia Spielmann, 等
出版事項: (2021-07-01)
Main NK cell receptors and their ligands: regulation by microRNAs
著者:: Stefano Regis, 等
出版事項: (2018-07-01)
著者:: Stefano Regis, 等
出版事項: (2018-07-01)
Genetic causes of human NK cell deficiency and their effect on NK cell subsets
著者:: Emily M. Mace, 等
出版事項: (2016-12-01)
著者:: Emily M. Mace, 等
出版事項: (2016-12-01)
New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
著者:: Mehmet Gunduz, 等
出版事項: (2021-09-01)
著者:: Mehmet Gunduz, 等
出版事項: (2021-09-01)
<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
著者:: V. G. Subrakova, 等
出版事項: (2020-03-01)
著者:: V. G. Subrakova, 等
出版事項: (2020-03-01)
Galectin-9 influences the Tim-3 molecule expression in natural killer different subpopulations
著者:: E. G. Orlova, 等
出版事項: (2023-06-01)
著者:: E. G. Orlova, 等
出版事項: (2023-06-01)
Therapeutic approaches to enhance natural killer cell cytotoxicity
著者:: Terran D. Stenger, 等
出版事項: (2024-03-01)
著者:: Terran D. Stenger, 等
出版事項: (2024-03-01)
Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer
著者:: Reza Darvishvand, 等
出版事項: (2024-04-01)
著者:: Reza Darvishvand, 等
出版事項: (2024-04-01)
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy
著者:: Massimo Fantini, 等
出版事項: (2023-11-01)
著者:: Massimo Fantini, 等
出版事項: (2023-11-01)
類似資料
-
Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities
著者:: Matthias Huyghe, 等
出版事項: (2024-10-01) -
Regulation of Tetraspanin CD63 in Chronic Myeloid Leukemia (CML): Single-Cell Analysis of Asymmetric Hematopoietic Stem Cell Division Genes
著者:: Christophe Desterke, 等
出版事項: (2025-07-01) -
Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance
著者:: Jusuf Imeri, 等
出版事項: (2023-03-01) -
HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease
著者:: Christophe Desterke, 等
出版事項: (2021-07-01) -
Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy
著者:: Masae Kishi, 等
出版事項: (2021-12-01)